Related Experiment Video

Updated: Mar 13, 2026

Delivery of the Cas9/sgRNA Ribonucleoprotein Complex in Immortalized and Primary Cells via Virus-like Particles "Nanoblades"
09:23

Delivery of the Cas9/sgRNA Ribonucleoprotein Complex in Immortalized and Primary Cells via Virus-like Particles "Nanoblades"

Published on: March 31, 2021

5.7K

Hepatitis C: how has France limited the expenses related to new treatments?

Anne-Laure Mouterde1, François Bocquet1,2,3, Isabelle Fusier1

  • 1a Evaluation and Proper Use of Health Products, General Agency of Equipment and Health Products , Assistance Publique-Hôpitaux de Paris (AP-HP) 7 rue du Fer à Moulin , 75005 Paris , France.

Expert Review of Pharmacoeconomics & Outcomes Research
|October 13, 2016
PubMed
Abstract

No abstract available in PubMed .

Keywords:
HCV treatmentdirect-acting antiviralsequityfinancing mechanismhepatitis Csustainabilityviral hepatitis

More Related Videos

Generation of Discriminative Human Monoclonal Antibodies from Rare Antigen-specific B Cells Circulating in Blood13:14

Generation of Discriminative Human Monoclonal Antibodies from Rare Antigen-specific B Cells Circulating in Blood

Published on: February 6, 2018

11.1K
Click-Chemistry Based Fluorometric Assay for Apolipoprotein N-acyltransferase from Enzyme Characterization to High-Throughput Screening07:37

Click-Chemistry Based Fluorometric Assay for Apolipoprotein N-acyltransferase from Enzyme Characterization to High-Throughput Screening

Published on: May 13, 2020

2.4K

Related Concept Videos